Home › Companies › Perspective Therapeutics, Inc. › 2025-2026

Perspective Therapeutics, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Perspective Therapeutics, Inc.’s Form 8-K, filed May 27, 2026 (Item 5.07 on EDGAR). Page generated November 1, 2026.

8Reported items
138Asset managers
1,105Fund votes
May 27, 2026Meeting date

Results at a glance

Meeting of May 27, 2026: 7 items on Perspective Therapeutics, Inc.’s Form 8-K, filed May 27, 2026: 1 approved · 6 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Perspective Therapeutics, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Perspective Therapeutics, Inc.

These tallies are Perspective Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Perspective Therapeutics, Inc. — official shareholder meeting results, meeting held May 27, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Lori A. Woods	69,622,536	--	--	7,660,689	20,599,237	90%	Not verified	—
Elect Director: Heidi Henson	74,298,922	--	--	2,984,303	20,599,237	96%	Not verified	—
Elect Director: Maya Martinez-Davis	77,085,447	--	--	197,778	20,599,237	99.7%	Not verified	—
Elect Director: Frank Morich, M.D., Ph.D.	62,317,819	--	--	14,965,406	20,599,237	81%	Not verified	—
Elect Director: Johan (Thijs) Spoor	77,090,696	--	--	192,529	20,599,237	99.7%	Not verified	—
Elect Director: Robert Froman Williamson, III	67,908,625	--	--	9,374,600	20,599,237	88%	Not verified	—
2. The Auditor Ratification Proposal	97,636,978	125,426	120,058	--	--	99.8%	Approved	—

Source: Perspective Therapeutics, Inc., Form 8-K, filed with the SEC on May 27, 2026 — read the filing on EDGAR.

How asset managers voted at the Perspective Therapeutics, Inc. 2025-2026 meeting

Each item below shows how the 138 asset managers that disclosed a Perspective Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Perspective Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Frank Morich, M.D., Ph.D.

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD

FOR: 62,317,819WITHHELD: 14,965,406

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Frank Morich, M.D., Ph.D.

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Frank Morich, M.D., Ph.D.”): 62,317,819 for, 14,965,406 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 9,943,299 for, 385,191 withheld, 1,827,440 abstained.

FORABSTAIN

FOR: 9,943,299ABSTAIN: 1,827,440WITHHOLD: 385,191

Largest asset managers voting on “Election of Directors: Frank Morich, M.D., Ph.D.” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	5,070,335	30	3,609	For
BlackRock	0	1,730,105	0	Abstain
State Street	1,642,640	0	0	For
Fidelity	865,299	0	0	For
TIAA	777,614	0	0	For
Charles Schwab	661,273	0	0	For
Voya	213,790	0	0	For
Invesco	0	0	203,396	Withhold
Dimensional	169,121	0	0	For
Equitable	48,740	0	95,140	Mixed
BRIDGEWAY FUNDS INC	89,546	0	0	For
Federated Hermes	81,491	0	0	For
QUANTITATIVE MASTER SERIES LLC	0	69,242	0	Abstain
ProShares	50,516	0	0	For
Direxion Shares ETF Trust	47,229	0	0	For
Lincoln Financial	42,100	0	0	For
AIG/SunAmerica	34,986	0	0	For
Northern Trust	33,309	0	0	For
Global X	0	0	28,196	Withhold
Bridge Builder Trust	0	28,063	0	Abstain
Pacific Life	0	0	23,634	Withhold
Brighthouse	20,137	0	0	For
John Hancock	16,606	0	0	For
Goldman Sachs	15,634	0	0	For
Nationwide	0	0	13,104	Withhold

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

2. Elect Director: Heidi Henson

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 74,298,922WITHHELD: 2,984,303

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Heidi Henson

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Heidi Henson”): 74,298,922 for, 2,984,303 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 11,639,765 for, 496,600 withheld, 19,565 abstained.

FOR

FOR: 11,639,765ABSTAIN: 19,565WITHHOLD: 496,600

Largest asset managers voting on “Election of Directors: Heidi Henson” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	5,073,968	6	0	For
BlackRock	1,730,105	0	0	For
State Street	1,640,722	0	1,918	For
Fidelity	865,299	0	0	For
TIAA	777,614	0	0	For
Charles Schwab	661,273	0	0	For
Voya	213,790	0	0	For
Invesco	203,396	0	0	For
Dimensional	0	0	169,121	Withhold
Equitable	143,880	0	0	For
BRIDGEWAY FUNDS INC	0	0	89,546	Withhold
Federated Hermes	81,491	0	0	For
QUANTITATIVE MASTER SERIES LLC	69,242	0	0	For
ProShares	0	0	50,516	Withhold
Direxion Shares ETF Trust	0	0	47,229	Withhold
Lincoln Financial	42,100	0	0	For
AIG/SunAmerica	0	0	34,986	Withhold
Northern Trust	0	0	33,309	Withhold
Global X	28,196	0	0	For
Bridge Builder Trust	28,063	0	0	For
Pacific Life	23,634	0	0	For
Brighthouse	0	0	20,137	Withhold
John Hancock	0	16,606	0	Abstain
Goldman Sachs	15,634	0	0	For
Nationwide	12,329	0	775	Mixed

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

3. Elect Director: Johan (Thijs) Spoor

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 77,090,696WITHHELD: 192,529

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Johan (Thijs) Spoor

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Johan (Thijs) Spoor”): 77,090,696 for, 192,529 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 12,155,930 for.

FOR

FOR: 12,155,930

Largest asset managers voting on “Election of Directors: Johan (Thijs) Spoor” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Vote
Vanguard	5,073,974	For
BlackRock	1,730,105	For
State Street	1,642,640	For
Fidelity	865,299	For
TIAA	777,614	For
Charles Schwab	661,273	For
Voya	213,790	For
Invesco	203,396	For
Dimensional	169,121	For
Equitable	143,880	For
BRIDGEWAY FUNDS INC	89,546	For
Federated Hermes	81,491	For
QUANTITATIVE MASTER SERIES LLC	69,242	For
ProShares	50,516	For
Direxion Shares ETF Trust	47,229	For
Lincoln Financial	42,100	For
AIG/SunAmerica	34,986	For
Northern Trust	33,309	For
Global X	28,196	For
Bridge Builder Trust	28,063	For
Pacific Life	23,634	For
Brighthouse	20,137	For
John Hancock	16,606	For
Goldman Sachs	15,634	For
Nationwide	13,104	For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

4. Elect Director: Lori A. Woods

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%

FOR: 69,622,536WITHHELD: 7,660,689

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Lori A. Woods

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Lori A. Woods”): 69,622,536 for, 7,660,689 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 10,178,238 for, 142,753 withheld, 1,834,939 abstained.

FORABSTAIN

FOR: 10,178,238ABSTAIN: 1,834,939WITHHOLD: 142,753

Largest asset managers voting on “Election of Directors: Lori A. Woods” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	5,062,836	7,529	3,609	For
BlackRock	0	1,730,105	0	Abstain
State Street	1,640,410	0	2,230	For
Fidelity	865,299	0	0	For
TIAA	777,614	0	0	For
Charles Schwab	661,273	0	0	For
Voya	213,790	0	0	For
Invesco	203,396	0	0	For
Dimensional	169,121	0	0	For
Equitable	48,740	0	95,140	Mixed
BRIDGEWAY FUNDS INC	89,546	0	0	For
Federated Hermes	81,491	0	0	For
QUANTITATIVE MASTER SERIES LLC	0	69,242	0	Abstain
ProShares	50,516	0	0	For
Direxion Shares ETF Trust	47,229	0	0	For
Lincoln Financial	42,100	0	0	For
AIG/SunAmerica	34,986	0	0	For
Northern Trust	33,309	0	0	For
Global X	28,196	0	0	For
Bridge Builder Trust	0	28,063	0	Abstain
Pacific Life	0	0	23,634	Withhold
Brighthouse	20,137	0	0	For
John Hancock	16,606	0	0	For
Goldman Sachs	15,634	0	0	For
Nationwide	775	0	12,329	Mixed

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

5. Elect Director: Maya Martinez-Davis

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 77,085,447WITHHELD: 197,778

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Maya Martinez-Davis

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Maya Martinez-Davis”): 77,085,447 for, 197,778 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 43 asset managers below reported 12,155,155 for, 775 withheld.

FOR

FOR: 12,155,155WITHHOLD: 775

Largest asset managers voting on “Election of Directors: Maya Martinez-Davis” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Withheld	Vote
Vanguard	5,073,974	0	For
BlackRock	1,730,105	0	For
State Street	1,642,640	0	For
Fidelity	865,299	0	For
TIAA	777,614	0	For
Charles Schwab	661,273	0	For
Voya	213,790	0	For
Invesco	203,396	0	For
Dimensional	169,121	0	For
Equitable	143,880	0	For
BRIDGEWAY FUNDS INC	89,546	0	For
Federated Hermes	81,491	0	For
QUANTITATIVE MASTER SERIES LLC	69,242	0	For
ProShares	50,516	0	For
Direxion Shares ETF Trust	47,229	0	For
Lincoln Financial	42,100	0	For
AIG/SunAmerica	34,986	0	For
Northern Trust	33,309	0	For
Global X	28,196	0	For
Bridge Builder Trust	28,063	0	For
Pacific Life	23,634	0	For
Brighthouse	20,137	0	For
John Hancock	16,606	0	For
Goldman Sachs	15,634	0	For
Nationwide	12,329	775	Mixed

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

6. Elect Director: Robert Froman Williamson, III

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%

FOR: 67,908,625WITHHELD: 9,374,600

Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Robert Froman Williamson, III

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Robert Froman Williamson, III”): 67,908,625 for, 9,374,600 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 6,985,069 for, 3,323,875 withheld, 1,846,986 abstained.

FORABSTAINWITHHOLD

FOR: 6,985,069ABSTAIN: 1,846,986WITHHOLD: 3,323,875

Largest asset managers voting on “Election of Directors: Robert Froman Williamson, III” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Vanguard	5,073,957	17	0	For
BlackRock	0	1,730,105	0	Abstain
State Street	3,460	0	1,639,180	Withhold
Fidelity	103,300	0	761,999	Mixed
TIAA	777,614	0	0	For
Charles Schwab	661,273	0	0	For
Voya	213,790	0	0	For
Invesco	0	0	203,396	Withhold
Dimensional	0	0	169,121	Withhold
Equitable	0	0	143,880	Withhold
BRIDGEWAY FUNDS INC	0	0	89,546	Withhold
Federated Hermes	81,491	0	0	For
QUANTITATIVE MASTER SERIES LLC	0	69,242	0	Abstain
ProShares	0	0	50,516	Withhold
Direxion Shares ETF Trust	0	0	47,229	Withhold
Lincoln Financial	0	0	42,100	Withhold
AIG/SunAmerica	0	0	34,986	Withhold
Northern Trust	0	0	33,309	Withhold
Global X	28,196	0	0	For
Bridge Builder Trust	0	28,063	0	Abstain
Pacific Life	0	0	23,634	Withhold
Brighthouse	0	0	20,137	Withhold
John Hancock	0	16,606	0	Abstain
Goldman Sachs	15,634	0	0	For
Nationwide	775	0	12,329	Mixed

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

7. To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the…

No official match Fund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

100% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR

Details: description as filed, votes by 138 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 43 asset managers voting on “To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation o” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Vote
Vanguard	0	--
BlackRock	0	--
State Street	0	--
Fidelity	0	--
TIAA	0	--
Charles Schwab	0	--
Voya	0	--
Invesco	0	--
Dimensional	0	--
Equitable	0	--
BRIDGEWAY FUNDS INC	0	--
Federated Hermes	0	--
QUANTITATIVE MASTER SERIES LLC	0	--
ProShares	0	--
Direxion Shares ETF Trust	0	--
Lincoln Financial	0	--
AIG/SunAmerica	0	--
Northern Trust	0	--
Global X	0	--
Bridge Builder Trust	0	--
Pacific Life	0	--
Brighthouse	20,137	For
John Hancock	0	--
Goldman Sachs	0	--
Nationwide	0	--

Fund voting reports, all 43 managers: 20,137 for, 11,955,991 1 year, 172,138 3 year, 7,664 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 109 asset managers voting on “To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation o” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Commodore Capital LP	0	0	0	0	--
Avidity Partners Management LP	0	0	0	0	--
State Street	0	0	0	0	--
Affinity Asset Advisors, LLC	0	0	0	0	--
BALYASNY ASSET MANAGEMENT L.P.	0	0	0	0	--
BlackRock	0	0	0	0	--
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	--
Citadel	0	0	0	0	--
Hills Bank & Trust Co	0	0	0	0	--
Nuveen	0	0	0	0	--
Charles Schwab	0	0	0	0	--
REGIONS FINANCIAL CORP	0	0	0	0	--
Vanguard	0	0	0	0	--
ADAR1 Capital Management, LLC	0	0	0	0	--
Voya	0	0	0	0	--
Northern Trust	0	0	0	0	--
PORTLAND INVESTMENT COUNSEL INC.	0	0	0	0	--
Two Sigma	0	0	0	0	--
Invesco	0	0	0	0	--
MELLON INVESTMENTS Corp	0	0	0	0	--
Fidelity	0	0	0	0	--
STATE OF WISCONSIN INVESTMENT BOARD	0	0	0	0	--
Wellington	0	0	0	0	--
Federated Hermes	0	0	0	0	--
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0	0	0	0	--

Institutional-manager reports, all 109 managers: 77,490 for, 2,991 abstained, 655 not voted, 27,508,250 1 year, 3,022 3 year. Showing the 25 largest; see all in the interactive database.

8. To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company…

No official matchAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR

Details: description as filed, votes by 43 asset managers

Description as filed by funds: To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.

The 43 asset managers below reported 12,155,930 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,155,930

Largest asset managers voting on “To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the” at Perspective Therapeutics, Inc., 2025-2026
Asset manager	For	Vote
Vanguard	5,073,974	For
BlackRock	1,730,105	For
State Street	1,642,640	For
Fidelity	865,299	For
TIAA	777,614	For
Charles Schwab	661,273	For
Voya	213,790	For
Invesco	203,396	For
Dimensional	169,121	For
Equitable	143,880	For
BRIDGEWAY FUNDS INC	89,546	For
Federated Hermes	81,491	For
QUANTITATIVE MASTER SERIES LLC	69,242	For
ProShares	50,516	For
Direxion Shares ETF Trust	47,229	For
Lincoln Financial	42,100	For
AIG/SunAmerica	34,986	For
Northern Trust	33,309	For
Global X	28,196	For
Bridge Builder Trust	28,063	For
Pacific Life	23,634	For
Brighthouse	20,137	For
John Hancock	16,606	For
Goldman Sachs	15,634	For
Nationwide	13,104	For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Largest Perspective Therapeutics, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 114,046,197 shares outstanding at the time of that meeting.

Fund voting reports: top Perspective Therapeutics, Inc. shareholders by shares voted on “To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the…”, 2025-2026
#	Asset manager	% of shares outstanding
1	Vanguard	4.45%
2	BlackRock	1.52%
3	State Street	1.44%
4	Fidelity	0.76%
5	TIAA	0.68%
6	Charles Schwab	0.58%
7	Voya	0.19%
8	Invesco	0.18%
9	Dimensional	0.15%
10	Equitable	0.13%

Institutional-manager reports: top Perspective Therapeutics, Inc. shareholders by shares voted on “To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the…”, 2025-2026
#	Asset manager	% of shares outstanding
1	Commodore Capital LP	5.56%
2	Avidity Partners Management LP	5.07%
3	State Street	2.01%
4	Affinity Asset Advisors, LLC	1.65%
5	BALYASNY ASSET MANAGEMENT L.P.	1.32%
6	BlackRock	0.98%
7	GEODE CAPITAL MANAGEMENT, LLC	0.79%
8	Citadel	0.78%
9	Hills Bank & Trust Co	0.76%
10	Nuveen	0.69%

Reported Perspective Therapeutics, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Perspective Therapeutics, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Lantheus Holdings, Inc.	7.66%	13D
Chen Yu	6.94%	13G
Qatar Investment Authority	6.20%	13G
Avidity Partners Management LP	5.30%	13G
BlackRock	4.69%	13F
Morgan Stanley	3.92%	13F
Millennium Management	3.55%	13F
Citadel Advisors	3.19%	13F
Vanguard Group	3.06%	13F
State Street	2.75%	13F

Percentages above are of 114,046,197 shares outstanding, as reported by Perspective Therapeutics, Inc. on its Form 10-Q dated May 6, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Perspective Therapeutics, Inc.’s 10-Q dated May 6, 2026. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.

At Perspective Therapeutics, Inc.'s shareholder meeting held May 27, 2026, in the 2025-2026 proxy season, 138 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,105 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Perspective Therapeutics, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the… — the reporting funds and managers cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Perspective Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.